地塞米松减轻脂质体布比卡因诱导的小鼠延迟性神经炎症
该研究在小鼠坐骨神经周围注射模型中比较了布比卡因与脂质体布比卡因(Exparel®)单独或联合地塞米松(腹腔或神经周围)的神经毒性与阻滞效果。结果显示神经周围地塞米松可减轻Exparel®诱导的延迟性神经炎症,而腹腔地塞米松无此作用;两种地塞米松途径均减轻布比卡因诱导的神经炎症。
要点
- 神经周围地塞米松可减轻Exparel®诱导的延迟性神经炎症。
- 腹腔或神经周围地塞米松均减轻布比卡因诱导的神经炎症。
- Exparel®组运动阻滞中位时长180分钟,热痛觉阻滞360分钟。
核心结论
- 神经周围或全身地塞米松对布比卡因诱导的神经炎症有保护作用。
- 仅神经周围地塞米松可减轻神经周围Exparel®诱导的延迟性炎症。
研究设计与样本
- 小鼠坐骨神经周围注射模型,共98只小鼠随机分为7组,每组14只。
- 分组包括假手术、布比卡因、布比卡因+腹腔地塞米松、布比卡因+神经周围地塞米松、Exparel®、Exparel®+腹腔地塞米松、Exparel®+神经周围地塞米松。
- 49只小鼠用于评估热痛觉和运动阻滞时长,每30分钟评估至恢复。
- 第14天或第28天处死小鼠行坐骨神经组织学评估。
主要发现
- B组小鼠第14天显示轻度神经炎症,E组小鼠第28天显示轻度神经炎症。
- 布比卡因组、布比卡因+腹腔地塞米松组、布比卡因+神经周围地塞米松组、Exparel®组、Exparel®+腹腔地塞米松组、Exparel®+神经周围地塞米松组的运动阻滞中位时长分别为90、120、120、120、180、180分钟。
- 上述对应组的热痛觉阻滞时长分别为240、300、360、360、360、420分钟。
临床怎么用
- 神经周围地塞米松可能作为减轻脂质体布比卡因延迟性神经炎症的辅助策略。
- 若需针对Exparel®的神经保护,全身(腹腔)地塞米松未显示减轻炎症的效果。
局限性
- 研究为小鼠模型,结果外推至临床需谨慎。
- 原文未报告炎症程度的定量评分及统计比较细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Liposomal bupivacaine (Exparel®) is a sustained-release formulation of bupivacaine for use in surgical infiltration anaesthesia. We analysed the histological nerve toxicity and clinical effectiveness of perineural Exparel® alone or with added dexamethasone in a mouse model. METHODS: We assigned 98 mice receiving a perineural sciatic nerve injection into seven groups: sham (n=14, perineural saline), B (n=14, perineural bupivacaine), BDIP (n=14, perineural bupivacaine + intraperitoneal dexamethasone), BDPN (n=14, perineural bupivacaine + perineural dexamethasone), E (n=14, perineural Exparel®), EDIP (n=14, perineural Exparel® + intraperitoneal dexamethasone), and EDPN (n=14, perineural Exparel® + perineural dexamethasone). The duration of thermoalgesic and motor block was evaluated in 49 mice (seven mice randomly selected by group) every 30 min until recovery. Mice were killed for sciatic nerve histological assessment at 14 or 28 days. RESULTS: The median duration of motor block was 90, 120, 120, 120, 180, and 180 min and the duration of thermoalgesic block was 240, 300, 360, 360, 360, and 420 min for groups B, BDIP, BDPN, E, EDIP, and EDPN, respectively. The B group mice showed mild neural inflammation at 14 days and the E group mice showed mild neural inflammation at 28 days. Addition (intraperitoneal or perineural) of dexamethasone reduced neural inflammation induced by bupivacaine, whereas only perineural dexamethasone reduced neural inflammation induced by Exparel®. CONCLUSIONS: Perineural or systemic dexamethasone had a protective effect against the neural inflammation induced by bupivacaine, and perineural dexamethasone attenuated delayed inflammation induced by perineural Exparel®.
引用
- Ferré F, Krin A, Sanchez M, et al. Perineural dexamethasone attenuates liposomal bupivacaine-induced delayed neural inflammation in mice in vivo. Br J Anaesth. 2020. PMID: 32593455. doi:10.1016/j.bja.2020.04.091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。